A Randomized Controlled Ixekizumab Vs Secukinumab Trial to Study the Impact on Sexual Activity in Adult Patients with Genital Psoriasis

References

• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.
   PubMed Web of Science ®Google Scholar
• Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis. 2005;64(Suppl 2):ii30–ii36.
   PubMedGoogle Scholar
• Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263–271.
   PubMed Web of Science ®Google Scholar
• Chon MP, Boehncke W-H. Psoriasis. N Engl J Med. 2005;352:1899–1912.
   PubMed Web of Science ®Google Scholar
• Ryan C, Sadlier M, De Vol E, et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol. 2015;72:978–983.
   PubMed Web of Science ®Google Scholar
• Cather JC, Ryan C, Meeuwis K, et al. Patients’ perspectives on the impact of genital psoriasis: a qualitative study. Dermatol Ther. 2017;7:447–461.
   PubMed Web of Science ®Google Scholar
• Meeuwis KA, de Hullu JA, Massuger LF, et al. Genital psoriasis: a systematic literature review on this hidden skin disease. Acta Derm Venereol. 2011;91:5–11.
   PubMed Web of Science ®Google Scholar
• Kelly A, Ryan C. Genital psoriasis: impact on quality of life and treatment options. Am J Clin Dermatol. 2019 Oct;20(5):639–646.
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Kuensebeck HW, Jaeger B, et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol. 1999;79:443–447.
   PubMed Web of Science ®Google Scholar
• Meeuwis KA, van de Kerkhof PC, Massuger LF, et al. Patients’ experience of psoriasis in the genital area. Dermatology. 2012;224:271–276.
   PubMed Web of Science ®Google Scholar
• Ryan C, Menter A, Guenther L, et al. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis. J Sex Med. 2018;15:S6–S7.
   Web of Science ®Google Scholar
• Merola JF, Bleakman AP, Gottlieb AB, et al. The static physician’s global assessment of genitalia: a clinical outcome measure for the severity of genital psoriasis. J Drugs Dermatol. 2017;16:793–799.
   PubMed Web of Science ®Google Scholar
• van Dorssen IE, Boom BW, Hengeveld MW. Experience of sexuality in patients with psoriasis and constitutional eczema. Ned Tijdschr Geneeskd. 1992;136:2175–2178.
   PubMedGoogle Scholar
• Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164:1247–1255.
   PubMed Web of Science ®Google Scholar
• Zamirska A, Reich A, Berny-Moreno J, et al. Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol. 2008;88:132–135.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Foley P, Ryan C, et al. Ixekizumab improved patient-reported genital psoriasis symptoms and impact of symptoms on sexual activity vs placebo in a randomized, double-blind study. J Sex Med. 2018;15(11):1645–1652.
   PubMed Web of Science ®Google Scholar
• Guenther L, Potts Bleakman A, Weisman J, et al. Ixekizumab results in persistent clinical improvement in moderate-to-severe genital psoriasis during a 52 week, randomized, placebo-controlled, phase 3 clinical trial. Acta Derm Venereol. 2020 Jan 7;100(1):adv00006.
   PubMed Web of Science ®Google Scholar
• McMahon CG, Jannini E, Waldinger M, et al. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10:204–229.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Kirby B, Ryan C, et al. The development of a patient-reported outcome measure for assessment of genital psoriasis symptoms: the genital psoriasis symptoms scale (GPSS). Dermatol Ther (Heidelb). 2018;8:45–56.
   PubMed Web of Science ®Google Scholar
• Burri A, Greven C, Leupin M, et al. A multivariate twin study of female sexual dysfunction. J Sex Med. 2012;9:2671–2681.
   PubMed Web of Science ®Google Scholar
• Labbate LA, Lare SB. Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts general hospital sexual functioning questionnaire. Psychother Psychosom. 2001;70(4):221–225.
   PubMed Web of Science ®Google Scholar
• Duarte GV, Calmon H, Radel G, et al. Psoriasis and sexual dysfunction: links, risks, and management challenges. Psoriasis (Auckl). 2018 Dec 10;8:93–99.
   PubMed Web of Science ®Google Scholar
• Kurizky PS, Martins GA, Carneiro JN, et al. Evaluation of the occurrence of sexual dysfunction and general quality of life in female patients with psoriasis. An Bras Dermatol. 2018 Nov/Dec;93(6):801–806.
   PubMed Web of Science ®Google Scholar
• Guenther L, Han C, Szapary P, et al. Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials. J Eur Acad Dermatol Venereol. 2011;25(7):851–857.
   PubMed Web of Science ®Google Scholar
• Guglielmetti A, Conlledo R, Bedoya J, et al. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther (Heidelb). 2012;2:15.
   PubMedGoogle Scholar
• Jemec GB, Baadsgaard O. Effect of cyclosporine on genital psoriasis and lichen planus. J Am Acad Dermatol. 1993;29:1048–1049.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Nigen S, Bolduc C. Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis. J Cutan Med Surg. 2008;12:230–234.
   PubMed Web of Science ®Google Scholar
• Rallis E, Nasiopoulou A, Kouskoukis C, et al. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp Clin Res. 2005;31:141–145.
   PubMedGoogle Scholar
• Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–385.
   PubMed Web of Science ®Google Scholar
• Molina-Leyva A, Salvador-Rodriguez L, Martinez-Lopez A, et al. Association between psoriasis and sexual and erectile dysfunction in epidemiologic studies: a systematic review. JAMA Dermatol. 2019 Jan 1;155(1):98–106.
   PubMed Web of Science ®Google Scholar
• Molina-Leyva A, Almodovar-Real A, Carrascosa JC, et al. Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis. An Bras Dermatol. 2015;90(3):338–345.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Kumaran MS, Narang T, et al. Genital psoriasis among Indians: a prospective cross-sectional study. Australas J Dermatol. 2015;56:e18–20.
   PubMed Web of Science ®Google Scholar
• Liao YH, Chiu HC, Tseng YS, et al. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(−1) ointment and tacrolimus 0.3 mg g(−1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br J Dermatol. 2007;157:1005–1012.
   PubMed Web of Science ®Google Scholar
• Martin Ezquerra G, Sanchez Regana M, Herrera Acosta E, et al. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol. 2006;5:334–336.
   PubMedGoogle Scholar
• Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61:451–485.
   PubMed Web of Science ®Google Scholar
• Czuczwar P, Stepniak A, Goren A, et al. Genital psoriasis: a hidden multidisciplinary problem—a review of literature. Ginekol Pol. 2016;87:717–721.
   PubMed Web of Science ®Google Scholar
• Meeuwis KA, de Hullu JA, IntHout J, et al. Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis. Acta Derm Venereol. 2015;95:211–216.
   PubMed Web of Science ®Google Scholar
• Kapila S, Bradford J, Fischer G. Vulvar psoriasis in adults and children: a clinical audit of 194 cases and review of the literature. J Lower Genit Tract Dis. 2012;16:364–371.
   PubMed Web of Science ®Google Scholar
• Aguirre MA, Ve´lez A, Romero M, et al. Gynecomastia and sexual impotence associated with methotrexate treatment. J Rheumatol. 2002;29:1793–1794.
   PubMed Web of Science ®Google Scholar
• Theodosiou G, Svensson Å. Methotrexate-associated sexual dysfunction: two case reports. Acta Derm Venereol. 2017 Oct 2;97(9):1132–1133.
   PubMed Web of Science ®Google Scholar
• Wylie G, Evans CD, Gupta G. Reduced libido and erectile dysfunction: rarely reported side-effects of methotrexate. Clin Exp Dermatol. 2009 Oct;34(7):e234.
   PubMed Web of Science ®Google Scholar
• Rossi M, Pellegrino M. Acitretin-associated erectile dysfunction: a case report. Cases J. 2009 Nov 19;2:210.
   PubMedGoogle Scholar
• Reynolds OD. Erectile dysfunction in etretinate treatment. Arch Dermatol. 1991;127:425–426.
   PubMedGoogle Scholar
• Ruiz-Villaverde R, Sánchez-Cano D, Rodrigo JR, et al. Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy. Indian J Dermatol. 2011;56(6):694–699.
   PubMedGoogle Scholar
• Dong X, Zheng Y, Shi TY, et al. Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis. Clin Rheumatol. 2015;34(5):915–920.
   PubMed Web of Science ®Google Scholar
• Burlando M, Herzum A, Carmisciano L, et al. Biological therapy in genital psoriasis in women. Dermatol Ther. 2020 Jan;33(1):e13110.
   PubMed Web of Science ®Google Scholar
• Ryan C, Menter A, Guenther L, et al.; IXORA-Q Study Group. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis. Br J Dermatol. 2018 Oct;179(4):844–852.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol. 1997 Apr;36(4):259–262.
   PubMed Web of Science ®Google Scholar
• Sampogna F, Gisondi P, Tabolli S, et al.; investigators IDIMPRoVE. Impairment of sexual life in patients with psoriasis. Dermatology. 2007;214:144–150.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236–244.
   PubMed Web of Science ®Google Scholar
• Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989;20:53–63.
   PubMed Web of Science ®Google Scholar
• Molina-Leyva A, Jiménez-Moleón JJ, Naranjo-Sintes R, et al. Sexual dysfunction in psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):649–655.
   PubMed Web of Science ®Google Scholar
• Merola JF, Ghislain PD, Dauendorffer JN, et al. Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis. J Eur Acad Dermatol Venereol. 2020 Jan 9;34:1257–1262.
   PubMed Web of Science ®Google Scholar